Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Neoplasms 16 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 8 Neoplasm Metastasis 7 Lung Neoplasms 7 Lymphoma 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Glioblastoma 5 Stomach Neoplasms 4 Leukemia 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Pain 3 Myelodysplastic Syndromes 3 Motor Activity 3 Melanoma 3 Fallopian Tube Neoplasms 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2

Interventions

Nivolumab 20 Ipilimumab 10 Paclitaxel 7 linrodostat 6 Standard of Care 6 Sirolimus 5 Gemcitabine 5 Bevacizumab 5 temsirolimus 4 relatlimab 4 Pemetrexed 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Vorinostat 3 Erlotinib Hydrochloride 3 Dasatinib 3 Cetuximab 3 regorafenib 2 olaparib 2 apatinib 2 anlotinib 2 abemaciclib 2 Trastuzumab 2 Surveys and Questionnaires 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Cancer × Palliative Care × Clear all

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡